Hohimer Wealth Management LLC Purchases 3,119 Shares of Cigna Group $CI

Hohimer Wealth Management LLC lifted its position in Cigna Group (NYSE:CI) by 18.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,408 shares of the health services provider’s stock after buying an additional 3,119 shares during the quarter. Hohimer Wealth Management LLC’s holdings in Cigna Group were worth $5,548,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. BlackRock Inc. lifted its stake in Cigna Group by 3.7% in the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after acquiring an additional 840,098 shares during the last quarter. GQG Partners LLC acquired a new position in shares of Cigna Group during the 2nd quarter worth $1,628,918,000. Bank of America Corp DE increased its stake in shares of Cigna Group by 8.8% during the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock worth $848,821,000 after purchasing an additional 256,677 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Cigna Group by 10.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock valued at $647,008,000 after purchasing an additional 236,340 shares in the last quarter. Finally, Legal & General Group Plc acquired a new stake in shares of Cigna Group in the 2nd quarter valued at $542,779,000. Institutional investors own 86.99% of the company’s stock.

Trending Headlines about Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CI. UBS Group reiterated a “buy” rating on shares of Cigna Group in a report on Thursday, October 1st. Evercore assumed coverage on Cigna Group in a report on Wednesday, September 9th. They set an “in-line” rating and a $290.00 target price on the stock. Robert W. Baird set a $362.00 price target on Cigna Group in a research report on Friday, July 31st. Piper Sandler reiterated an “overweight” rating on shares of Cigna Group in a research note on Friday, October 23rd. Finally, Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price objective for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $335.70.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $293.66 on Monday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66. The firm has a fifty day simple moving average of $285.81 and a 200-day simple moving average of $282.17. The stock has a market capitalization of $77.60 billion, a price-to-earnings ratio of 12.96, a PEG ratio of 1.01 and a beta of 0.25. Cigna Group has a 1-year low of $255.53 and a 1-year high of $318.05.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. The business had revenue of $73.79 billion for the quarter, compared to analyst estimates of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. Cigna Group’s revenue was up 5.6% compared to the same quarter last year. During the same period last year, the business posted $7.83 EPS. On average, sell-side analysts expect that Cigna Group will post 30.62 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be paid a $1.56 dividend. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s payout ratio is presently 27.54%.

Insider Activity

In other Cigna Group news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Cigna Group Profile

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.